Cytokine polymorphisms in the Tb1/Th2 pathway and susceptibility to non-Hodgkin lymphoma
Cytokine polymorphisms in the Tb1/Th2 pathway and susceptibility to non-Hodgkin lymphoma
复制标题
DOI:
10.1182/blood-2005-10-4160
复制
发表时间:
2006-05-15
期刊:
影响因子:
20.3
通讯作者:
Chanock, Stephen
中科院分区:
文献类型:
--
作者:
Lan, Qing;Zheng, Tongzhang;Chanock, Stephen
Studies have demonstrated that common polymorphisms in Th1 and Th2 cytokine genes can alter gene expression, modulate the balance between Th1/Th2 responsiveness, and influence susceptibility for autoimmune disorders, infectious diseases, and cancer. We analyzed one or more single nucleotide polymorphisms (SNPs) in 20 candidate Th1/Th2 genes in a population-based case-control study of non-Hodgkin lymphoma (NHL; n = 518 cases, 597 controls) among women in Connecticut. SNPs in critical genes, IL4, IL5, IL6, and 100, were associated with risk for NHL and in some instances with a specific histologic subtype. Analysis of 4 SNPs in the IL10 promoter (-3575T > A, -1082A > G, -819C > T, and -592C > A) revealed that both the AGCC haplotype (odds ratio [OR] = 1.54, 95% confidence interval [CI] = 1.21-1.96, P < .001) and the TATA haplotype (OR = 1.37, 95% CI = 1.05-1.79, P = .02) were associated with increased risk for B-cell lymphomas. In contrast, the IL4-1098G allele was associated with increased risk of T-cell lymphomas (OR = 3.84; 95% C1 = 1.79-8.22; P < .001). Further, the IL10 and IL4 SNP associations remained significant after adjusting for multiple comparisons. These results suggest that SNPs in Th2 cytokine genes may be associated with risk of NHL.